Unknown

Dataset Information

0

Persistence with generic imatinib for chronic myeloid leukemia: a matched cohort study.

ABSTRACT:

SUBMITTER: Klil-Drori AJ 

PROVIDER: S-EPMC6601075 | biostudies-literature | 2019 Jul

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Persistence with generic imatinib for chronic myeloid leukemia: a matched cohort study.

Klil-Drori Adi J AJ   Yin Hui H   Azoulay Laurent L   Harnois Michaël M   Gratton Michel-Olivier MO   Busque Lambert L   Assouline Sarit E SE  

Haematologica 20190110 7

Similar Datasets

Unknown Comparable efficacy and safety of generic and branded imatinib for patients with chronic myeloid leukemia in China.
| S-EPMC11325334 | biostudies-literature
Unknown Retroviral insertional mutagenesis identifies RUNX genes involved in chronic myeloid leukemia disease persistence under imatinib treatment.
| S-EPMC1810334 | biostudies-literature
Unknown Pioglitazone together with imatinib in chronic myeloid leukemia: A proof of concept study.
| S-EPMC5434901 | biostudies-literature
Unknown Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States.
| S-EPMC4948567 | biostudies-literature
Unknown Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia.
| S-EPMC5901965 | biostudies-literature
Unknown Rapid conversion of chronic myeloid leukemia to chronic myelomonocytic leukemia in a patient on imatinib therapy.
| S-EPMC5093026 | biostudies-literature
Unknown Imatinib dose reduction after major molecular response in chronic-phase chronic myeloid leukemia.
| S-EPMC11694160 | biostudies-literature
Unknown Hyaluronan abrogates imatinib-induced senescence in chronic myeloid leukemia cell lines.
| S-EPMC6662747 | biostudies-literature
Unknown CFL1 is Implicated in Chronic Myeloid Leukemia Response during Imatinib Therapy.
| S-EPMC10937266 | biostudies-literature
Unknown First-line treatment for chronic myeloid leukemia: dasatinib, nilotinib, or imatinib.
| S-EPMC3000369 | biostudies-literature